ANI Pharmaceuticals to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ

Rhea-AI Summary

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) has announced that CEO Nikhil Lalwani and CFO Stephen Carey will present at the H.C. Wainwright BioConnect Investor Conference on May 2, 2023, at 12:00 p.m. ET in New York City. The event will be available via webcast.

Investors can access the live presentation by clicking here. The recorded version will be available on demand starting May 3, 2023, at 7:00 a.m. ET for 90 days.

ANI Pharmaceuticals focuses on developing, manufacturing, and marketing high-quality pharmaceutical products, including those for unmet medical needs.

BAUDETTE, Minn.--(BUSINESS WIRE)-- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the H.C. Wainwright BioConnect Investor Conference at the NASDAQ Headquarters in New York City as follows:

Date:							Tuesday, May 2, 2023
Time:							12:00 p.m. ET
Webcast:							Click Here

The webcast will be accessible on demand beginning on May 3, 2023, at 7:00 a.m. ET and archived for 90 days thereafter, via the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations.

About ANI

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by building a successful Purified Cortrophin® Gel franchise, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230426005978/en/

Investor Relations:

Lisa M. Wilson, In-Site Communications, Inc.

T: 212-452-2793

E: lwilson@insitecony.com

Source: ANI Pharmaceuticals, Inc.

FAQ

When will ANI Pharmaceuticals present at the H.C. Wainwright BioConnect Investor Conference?

ANI Pharmaceuticals will present on May 2, 2023, at 12:00 p.m. ET.

Where is the H.C. Wainwright BioConnect Investor Conference taking place?

The conference will be held at the NASDAQ Headquarters in New York City.

How can I access the webcast of ANI Pharmaceuticals' presentation?

You can access the webcast by clicking on the provided link in their press release.

When will the webcast of ANI Pharmaceuticals’ presentation be available on demand?

The webcast will be available on demand starting May 3, 2023, at 7:00 a.m. ET.

What is the focus of ANI Pharmaceuticals?

ANI Pharmaceuticals focuses on developing and marketing high-quality branded and generic prescription pharmaceutical products.